Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

Abstract Objective To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. Design Analysis of prospective data from a multiethnic population based cohort. Setting Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. Participants 10 276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. Main outcome measures Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease. Results Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index ≥ 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04). Conclusions Obesity in middle age increases the risk of future dementia independently of comorbid conditions.

[1]  L. Hirsch Competing interests: none declared. , 2006 .

[2]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[3]  C. Björkelund,et al.  A 24-year follow-up of body mass index and cerebral atrophy , 2004, Neurology.

[4]  A. Newman,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.

[5]  I. Skoog,et al.  Body mass index and white matter lesions in elderly women. An 18-year longitudinal study , 2004, International Psychogeriatrics.

[6]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[7]  Tosca L. Zern,et al.  Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. , 2004, The Journal of nutrition.

[8]  G. Bray Obesity is a chronic, relapsing neurochemical disease , 2004, International Journal of Obesity.

[9]  Deborah Gustafson,et al.  An 18-year follow-up of overweight and risk of Alzheimer disease. , 2003, Archives of internal medicine.

[10]  S. Rubin,et al.  Inflammatory markers and cognition in well-functioning African-American and white elders , 2003, Neurology.

[11]  P. Ghenev,et al.  Adipobiology of disease: adipokines and adipokine-targeted pharmacology. , 2003, Current pharmaceutical design.

[12]  J. Harvey Novel actions of leptin in the hippocampus , 2003, Annals of medicine.

[13]  S. Shioda,et al.  Distribution, function, and properties of leptin receptors in the brain. , 2003, International review of cytology.

[14]  C. Tanner,et al.  Midlife adiposity and the future risk of Parkinson’s disease , 2002, Neurology.

[15]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[16]  San-Yi Wang Weight loss and metabolic changes in dementia. , 2002, The journal of nutrition, health & aging.

[17]  U. Das Is obesity an inflammatory condition? , 2001, Nutrition.

[18]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[19]  P. Sweetnam,et al.  Central obesity: predictive value of skinfold measurements for subsequent ischaemic heart disease at 14 years follow-up in the Caerphilly Study , 2001, International Journal of Obesity.

[20]  M González-Gross,et al.  Nutrition and cognitive impairment in the elderly , 2001, British Journal of Nutrition.

[21]  C. Fjeld,et al.  Nutritional reversion of cognitive impairment in the elderly. , 2001, Nestle Nutrition workshop series. Clinical & performance programme.

[22]  R. Brookmeyer,et al.  Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease. , 2000, Statistics in Medicine.

[23]  B. Sternfeld,et al.  Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. , 2000, JAMA.

[24]  M. Breteler Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study , 2000, Annals of the New York Academy of Sciences.

[25]  K. Yano,et al.  The association of body weight and anthropometry with mortality in elderly men: The Honolulu Heart Program , 1999, International Journal of Obesity.

[26]  J. Knittweis WEIGHT LOSS PRECEDES ALZHEIMER'S DISEASE SYMPTOMS: A CASE STUDY , 1998, Journal of the American Geriatrics Society.

[27]  E. Barrett-Connor,et al.  Weight Loss Precedes Dementia in Community‐Dwelling Older Adults , 1996, The journal of nutrition, health & aging.

[28]  L A Beckett,et al.  Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.

[29]  R. Bergman,et al.  Insulin Sensitivity and Abdominal Obesity in African-American, Hispanic, and Non-Hispanic White Men and Women: The Insulin Resistance and Atherosclerosis Study , 1996, Diabetes.

[30]  S. Heymsfield,et al.  Human body composition and the epidemiology of chronic disease. , 1995, Obesity research.

[31]  N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[32]  U. Smith,et al.  Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. , 1990, Metabolism: clinical and experimental.

[33]  G. Friedman,et al.  Precursors of essential hypertension. The role of body fat distribution pattern. , 1989, American journal of epidemiology.

[34]  R E Smith,et al.  The California Automated Mortality Linkage System (CAMLIS). , 1984, American journal of public health.

[35]  M F Collen,et al.  The Multitest Laboratory in Health Care , 1969, Occupational health nursing.

[36]  RECOMMENDATIONS concerning body measurements for the characterization of nutritional status. , 1956, Human biology.